Archean Chemical (ACI)’s Q1FY27 EBITDA shrank 13.9% YoY weighed down by the salts business and higher logistics costs. QoQ, EBITDA rose 53.9% with a recovery in bromine volumes and prices. ACI’s Acume Chemicals (bromine derivative) has achieved EBITDA break-even.